{{Rsnum
|rsid=10508921
|Chromosome=10
|position=52010708
|Orientation=plus
|GMAF=0.1625
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 85.0 | 14.2 | 0.9
| HCB | 47.8 | 40.4 | 11.8
| JPT | 47.8 | 42.5 | 9.7
| YRI | 75.5 | 21.1 | 3.4
| ASW | 71.9 | 26.3 | 1.8
| CHB | 47.8 | 40.4 | 11.8
| CHD | 39.4 | 44.0 | 16.5
| GIH | 62.4 | 34.7 | 3.0
| LWK | 80.0 | 17.3 | 2.7
| MEX | 81.0 | 19.0 | 0.0
| MKK | 83.9 | 16.1 | 0.0
| TSI | 83.3 | 14.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=T
  |Pval=9E-7
  |OR=25.70
  |ORtxt=[15.47-35.93] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}